115 related articles for article (PubMed ID: 16534114)
1. Memory impairment in now abstinent MDMA users and continued users: a longitudinal follow-up.
Zakzanis KK; Campbell Z
Neurology; 2006 Mar; 66(5):740-1. PubMed ID: 16534114
[TBL] [Abstract][Full Text] [Related]
2. Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users: the longitudinal perspective.
Thomasius R; Zapletalova P; Petersen K; Buchert R; Andresen B; Wartberg L; Nebeling B; Schmoldt A
J Psychopharmacol; 2006 Mar; 20(2):211-25. PubMed ID: 16510479
[TBL] [Abstract][Full Text] [Related]
3. Memory performance in polyvalent MDMA (ecstasy) users who continue or discontinue MDMA use.
Gouzoulis-Mayfrank E; Fischermann T; Rezk M; Thimm B; Hensen G; Daumann J
Drug Alcohol Depend; 2005 Jun; 78(3):317-23. PubMed ID: 15893163
[TBL] [Abstract][Full Text] [Related]
4. Memory deficits in abstinent MDMA (ecstasy) users: neuropsychological evidence of frontal dysfunction.
Quednow BB; Jessen F; Kuhn KU; Maier W; Daum I; Wagner M
J Psychopharmacol; 2006 May; 20(3):373-84. PubMed ID: 16574711
[TBL] [Abstract][Full Text] [Related]
5. Neural mechanisms of working memory in ecstasy (MDMA) users who continue or discontinue ecstasy and amphetamine use: evidence from an 18-month longitudinal functional magnetic resonance imaging study.
Daumann J; Fischermann T; Heekeren K; Thron A; Gouzoulis-Mayfrank E
Biol Psychiatry; 2004 Sep; 56(5):349-55. PubMed ID: 15336517
[TBL] [Abstract][Full Text] [Related]
6. Memory impairment suggests hippocampal dysfunction in abstinent ecstasy users.
Gouzoulis-Mayfrank E; Thimm B; Rezk M; Hensen G; Daumann J
Prog Neuropsychopharmacol Biol Psychiatry; 2003 Aug; 27(5):819-27. PubMed ID: 12921915
[TBL] [Abstract][Full Text] [Related]
7. Visuo-spatial working memory deficits in current and former users of MDMA ('ecstasy').
Wareing M; Fisk JE; Murphy P; Montgomery C
Hum Psychopharmacol; 2005 Mar; 20(2):115-23. PubMed ID: 15641126
[TBL] [Abstract][Full Text] [Related]
8. Patterns of memory dysfunction in current and 2-year abstinent MDMA users.
Ward J; Hall K; Haslam C
J Clin Exp Neuropsychol; 2006 Apr; 28(3):306-24. PubMed ID: 16618622
[TBL] [Abstract][Full Text] [Related]
9. Memory function and serotonin transporter promoter gene polymorphism in ecstasy (MDMA) users.
Reneman L; Schilt T; de Win MM; Booij J; Schmand B; van den Brink W; Bakker O
J Psychopharmacol; 2006 May; 20(3):389-99. PubMed ID: 16574713
[TBL] [Abstract][Full Text] [Related]
10. Cognitive performance in recreational ecstasy polydrug users: a two-year follow-up study.
de Sola Llopis S; Miguelez-Pan M; Peña-Casanova J; Poudevida S; Farré M; Pacifici R; Böhm P; Abanades S; Verdejo García A; Langohr K; Zuccaro P; de la Torre R
J Psychopharmacol; 2008 Jul; 22(5):498-510. PubMed ID: 18208910
[TBL] [Abstract][Full Text] [Related]
11. Beyond the K-hole: a 3-year longitudinal investigation of the cognitive and subjective effects of ketamine in recreational users who have substantially reduced their use of the drug.
Morgan CJ; Monaghan L; Curran HV
Addiction; 2004 Nov; 99(11):1450-61. PubMed ID: 15500598
[TBL] [Abstract][Full Text] [Related]
12. Verbal working memory deficits in current and previous users of MDMA.
Wareing M; Fisk JE; Murphy P; Montgomery C
Hum Psychopharmacol; 2004 Jun; 19(4):225-34. PubMed ID: 15181650
[TBL] [Abstract][Full Text] [Related]
13. Syllogistic reasoning performance in MDMA (Ecstasy) users.
Montgomery C; Fisk JE; Newcombe R; Wareing M; Murphy PN
Exp Clin Psychopharmacol; 2005 May; 13(2):137-45. PubMed ID: 15943546
[TBL] [Abstract][Full Text] [Related]
14. Lasting neuropsychiatric sequelae of (+-)methylenedioxymethamphetamine ('ecstasy') in recreational users.
McCann UD; Ricaurte GA
J Clin Psychopharmacol; 1991 Oct; 11(5):302-5. PubMed ID: 1684975
[TBL] [Abstract][Full Text] [Related]
15. Cognitive performance in light current users and ex-users of ecstasy (MDMA) and controls.
Golding JF; Groome DH; Rycroft N; Denton Z
Am J Drug Alcohol Abuse; 2007; 33(2):301-7. PubMed ID: 17497553
[TBL] [Abstract][Full Text] [Related]
16. Memory impairment in abstinent MDMA ("Ecstasy") users: a longitudinal investigation.
Zakzanis KK; Young DA
Neurology; 2001 Apr; 56(7):966-9. PubMed ID: 11294938
[TBL] [Abstract][Full Text] [Related]
17. MDMA polydrug users show process-specific central executive impairments coupled with impaired social and emotional judgement processes.
Reay JL; Hamilton C; Kennedy DO; Scholey AB
J Psychopharmacol; 2006 May; 20(3):385-8. PubMed ID: 16574712
[TBL] [Abstract][Full Text] [Related]
18. Combined immunomodulating properties of 3,4-methylenedioxymethamphetamine (MDMA) and cannabis in humans.
Pacifici R; Zuccaro P; Farré M; Poudevida S; Abanades S; Pichini S; Langohr K; Segura J; de la Torre R
Addiction; 2007 Jun; 102(6):931-6. PubMed ID: 17523988
[TBL] [Abstract][Full Text] [Related]
19. Attentional processes in abstinent methylenedioxymethamphetamine (ecstasy) users.
Zakzanis KK; Young DA; Radkhoshnoud NF
Appl Neuropsychol; 2002; 9(2):84-91. PubMed ID: 12214826
[TBL] [Abstract][Full Text] [Related]
20. MDMA, methamphetamine and their combination: possible lessons for party drug users from recent preclinical research.
Clemens KJ; McGregor IS; Hunt GE; Cornish JL
Drug Alcohol Rev; 2007 Jan; 26(1):9-15. PubMed ID: 17364831
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]